THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) today announces that Dr. Paul Lammers has joined the company as its President. Dr. Lammers brings broad executive, commercial, clinical and regulatory experience in the pharmaceutical and biotech industry with substantial expertise in reproductive health. Joseph Podolski remains as the Company’s Chief Executive Officer and a director.
